📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Ketamine for the treatment of addiction: Evidence and potential mechanisms. (2018)

First Author: Ivan Ezquerra-Romano I

Attributed to: Reducing relapse in alcohol dependence with the NMDA receptor antagonist, ketamine funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.neuropharm.2018.01.017

PubMed Identifier: 29339294

Publication URI: http://europepmc.org/abstract/MED/29339294

Type: Journal Article/Review

Volume: 142

Parent Publication: Neuropharmacology

ISSN: 0028-3908